Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 0.776 Q1 | 192 | 335 | 1214 | 38296 | 5194 | 1130 | 3.90 | 114.32 | |
2 | Current Pharmaceutical Design | journal | 0.580 Q2 | 176 | 329 | 1399 | 30191 | 4651 | 1281 | 2.99 | 91.77 | |
3 | Current Topics in Medicinal Chemistry | journal | 0.516 Q2 | 127 | 191 | 680 | 18928 | 1968 | 550 | 2.77 | 99.10 | |
4 | Current Neuropharmacology | journal | 1.168 Q1 | 93 | 156 | 307 | 20941 | 1937 | 293 | 5.01 | 134.24 | |
5 | Mini-Reviews in Medicinal Chemistry | journal | 0.570 Q2 | 101 | 162 | 449 | 17321 | 1935 | 442 | 4.02 | 106.92 | |
6 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.428 Q3 | 103 | 286 | 635 | 21787 | 1755 | 622 | 2.77 | 76.18 | |
7 | Current Drug Targets | journal | 0.621 Q2 | 112 | 110 | 419 | 12345 | 1440 | 403 | 3.13 | 112.23 | |
8 | Current Bioinformatics | journal | 0.467 Q3 | 34 | 83 | 325 | 4428 | 1153 | 313 | 3.97 | 53.35 | |
9 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.427 Q3 | 60 | 140 | 554 | 10373 | 1139 | 540 | 1.97 | 74.09 | |
10 | Current Organic Chemistry | journal | 0.407 Q3 | 110 | 118 | 417 | 12947 | 1056 | 390 | 2.37 | 109.72 | |
11 | Current Protein and Peptide Science | journal | 0.612 Q2 | 92 | 74 | 299 | 6244 | 959 | 277 | 2.53 | 84.38 | |
12 | Current Alzheimer Research | journal | 0.637 Q2 | 100 | 78 | 336 | 5600 | 923 | 324 | 2.14 | 71.79 | |
13 | Current Drug Delivery | journal | 0.391 Q2 | 68 | 87 | 292 | 5415 | 900 | 280 | 2.54 | 62.24 | |
14 | Current Diabetes Reviews | journal | 0.696 Q2 | 65 | 92 | 280 | 7717 | 873 | 274 | 3.34 | 83.88 | |
15 | Current Cancer Drug Targets | journal | 0.687 Q2 | 99 | 69 | 228 | 5875 | 723 | 219 | 2.95 | 85.14 | |
16 | Current Stem Cell Research and Therapy | journal | 0.552 Q2 | 61 | 63 | 235 | 5371 | 704 | 221 | 2.36 | 85.25 | |
17 | Current Vascular Pharmacology | journal | 0.917 Q1 | 67 | 60 | 187 | 4056 | 702 | 153 | 3.86 | 67.60 | |
18 | Current Medical Imaging | journal | 0.263 Q3 | 31 | 193 | 440 | 6752 | 659 | 421 | 1.52 | 34.98 | |
19 | CNS and Neurological Disorders - Drug Targets | journal | 0.574 Q2 | 93 | 81 | 217 | 8156 | 634 | 205 | 2.87 | 100.69 | |
20 | Medicinal Chemistry | journal | 0.324 Q3 | 48 | 83 | 270 | 4451 | 599 | 264 | 2.19 | 53.63 | |
21 | Combinatorial Chemistry and High Throughput Screening | journal | 0.271 Q3 | 68 | 227 | 359 | 11783 | 568 | 333 | 1.66 | 51.91 | |
22 | Current Analytical Chemistry | journal | 0.305 Q3 | 36 | 97 | 293 | 7054 | 566 | 278 | 1.84 | 72.72 | |
23 | Current Molecular Pharmacology | journal | 0.694 Q2 | 46 | 71 | 166 | 7930 | 515 | 157 | 2.65 | 111.69 | |
24 | Current Organic Synthesis | journal | 0.377 Q3 | 53 | 58 | 208 | 3660 | 502 | 191 | 1.67 | 63.10 | |
25 | Infectious Disorders - Drug Targets | journal | 0.298 Q3 | 59 | 100 | 328 | 4928 | 479 | 311 | 1.40 | 49.28 | |
26 | Emirates Journal of Food and Agriculture | journal | 0.284 Q3 | 37 | 111 | 335 | 5058 | 464 | 335 | 1.31 | 45.57 | |
27 | Mini-Reviews in Organic Chemistry | journal | 0.370 Q3 | 42 | 62 | 191 | 5350 | 457 | 182 | 2.27 | 86.29 | |
28 | Current Genomics | journal | 0.548 Q3 | 73 | 35 | 176 | 2147 | 454 | 153 | 2.40 | 61.34 | |
29 | Current Gene Therapy | journal | 0.564 Q2 | 78 | 36 | 122 | 3105 | 436 | 107 | 3.32 | 86.25 | |
30 | Current Neurovascular Research | journal | 0.424 Q3 | 57 | 56 | 214 | 2297 | 393 | 199 | 1.99 | 41.02 | |
31 | Current Drug Discovery Technologies | journal | 0.329 Q3 | 46 | 40 | 194 | 2318 | 391 | 189 | 1.68 | 57.95 | |
32 | Current Cardiology Reviews | journal | 0.536 Q2 | 55 | 63 | 156 | 4269 | 390 | 146 | 1.68 | 67.76 | |
33 | Current Nanoscience | journal | 0.284 Q3 | 51 | 64 | 236 | 5132 | 379 | 228 | 1.58 | 80.19 | |
34 | Open Dentistry Journal | journal | 0.218 Q3 | 33 | 95 | 291 | 3432 | 379 | 278 | 1.33 | 36.13 | |
35 | Current Nutrition and Food Science | journal | 0.223 Q3 | 30 | 87 | 358 | 5752 | 378 | 353 | 1.06 | 66.11 | |
36 | Letters in Drug Design and Discovery | journal | 0.192 Q3 | 36 | 89 | 355 | 4304 | 370 | 329 | 1.08 | 48.36 | |
37 | Current Pediatric Reviews | journal | 0.701 Q2 | 30 | 35 | 105 | 2250 | 363 | 98 | 2.18 | 64.29 | |
38 | Clinical Practice and Epidemiology in Mental Health | journal | 0.906 Q2 | 55 | 24 | 90 | 1148 | 333 | 78 | 3.72 | 47.83 | |
39 | Current Computer-Aided Drug Design | journal | 0.258 Q3 | 31 | 42 | 195 | 1983 | 320 | 187 | 1.73 | 47.21 | |
40 | Letters in Organic Chemistry | journal | 0.186 Q4 | 32 | 140 | 363 | 5451 | 315 | 333 | 0.86 | 38.94 | |
41 | Current Bioactive Compounds | journal | 0.207 Q3 | 29 | 79 | 280 | 4374 | 311 | 272 | 1.00 | 55.37 | |
42 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.558 Q2 | 48 | 35 | 97 | 3255 | 293 | 92 | 2.65 | 93.00 | |
43 | Recent advances in inflammation & allergy drug discovery | journal | 0.973 Q1 | 34 | 15 | 44 | 896 | 247 | 39 | 2.67 | 59.73 | |
44 | Current Rheumatology Reviews | journal | 0.381 Q3 | 27 | 49 | 151 | 2139 | 232 | 146 | 1.36 | 43.65 | |
45 | Current Pharmaceutical Analysis | journal | 0.178 Q3 | 26 | 88 | 340 | 4225 | 231 | 335 | 0.66 | 48.01 | |
46 | Reviews on Recent Clinical Trials | journal | 0.377 Q3 | 34 | 46 | 136 | 1902 | 224 | 119 | 1.58 | 41.35 | |
47 | Current Hypertension Reviews | journal | 0.437 Q3 | 26 | 20 | 82 | 1274 | 196 | 72 | 2.05 | 63.70 | |
48 | Current Reviews in Clinical and Experimental Pharmacology | journal | 0.406 Q2 | 45 | 26 | 99 | 1407 | 188 | 94 | 1.74 | 54.12 | |
49 | Current Radiopharmaceuticals | journal | 0.379 Q3 | 30 | 38 | 99 | 1789 | 183 | 87 | 1.69 | 47.08 | |
50 | Recent Patents on Nanotechnology | journal | 0.308 Q2 | 33 | 26 | 83 | 1832 | 175 | 78 | 2.05 | 70.46 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2022. Data Source: Scopus®